Research Article
Clinical and Biochemical Characteristics of Iraqi Patients with Rheumatoid Arthritis According to Treatment Status: A Comparative Study
- By Esraa S. Al-Fatlawey, Lina A. Hassan - 18 Nov 2026
- Current Research in Health Sciences, Volume: 4, Issue: 2, Pages: 83 - 88
- https://doi.org/10.58613/crhs4211
- Received: 20.09.2026; Accepted: 05.11.2026; Published: 18.11.2026
Abstract
Background: Rheumatoid arthritis (RA) is a chronic systemic autoimmune disorder characterized by persistent inflammation and potential alterations in biochemical and inflammatory parameters. Disease-modifying antirheumatic drugs (DMARDs) are used to control disease activity and limit disease progression; however, treatment-related changes in laboratory parameters require continued evaluation. Objective: To compare selected inflammatory and biochemical parameters among Iraqi patients with RA according to treatment status and with apparently healthy controls. Methods: This observational study, which is comparative in nature, encompassed 84 individuals diagnosed with RA who visited Al-Sadder Hospital, Al-Najaf, Iraq, from November and December 2024. Subject were divided into a treated cohort (n = 30) and an untreated cohort (n = 54), and have been compared with 20 presumably healthy controls. The participant’s ages were from 17 to 80 years. Alanine aminotransferase (ALT), aspartate aminotransferase (AST), Erythrocyte sedimentation rate (ESR), and serum urea were assessed. The characteristics of the group and laboratory measures were compared using statistical techniques outlines in the study protocol. Results: Females represented 78.6% of the rheumatoid arthritis patients (66/84). The 38 to 58- year- age cohort represented the most significant age group within the RA patient’s population (32/84, 38.1%). The mean ESR readings were 36.7 mm/h among patients receiving treatment, 62 mm/h among those not receiving treatment, and 13.5 mm/h in the control group. The mean values of ALT were 14, 18.4, and 26.5 U/L, respectively, whereas the mean value for AST values were 18, 19, and 23.4 U/L. The finding suggests variations in these characteristics across the research cohort. Conclusion: The results reveal disparities in certain inflammatory and biochemical markers between rheumatoid arthritis patients and healthy controls, along with noticeable differences between treated and untreated patients. Additional researches with well-defined treatment protocol, suitable adjustment for confounders variables, and extended follow-up is required to determine the relationship between particular therapies and laboratory results.
Authors affiliation:
Esraa S. Al-Fatlawey (ORCID): Faculty of science, Department of Pathological Analyses, University of Kufa, Najaf, Iraq.
Lina A. Hassan (ORCID): Faculty of science, Department of Pathological Analyses, University of Kufa, Najaf, Iraq.
How To Cite: E. S. Al-Fatlawey and L. A. Hassan. Clinical and Biochemical Characteristics of Iraqi Patients with Rheumatoid Arthritis According to Treatment Status: A Comparative Study. Current Research in Health Sciences, 4(2):83–88, 2026. https://doi.org/10.58613/crhs4211